Measuring early childhood development in Brazil: validation of the Caregiver Reported Early Development Instruments (CREDI)

Altafim, Elisa Rachel Pisani; McCoy, Dana Charles; Brentani, Alexandra; Escobar, Ana Maria de Ulhôa; Grisi, Sandra; Fink, Günther

doi:10.1016/j.jped.2018.07.008

Cited by 27 publications

(25 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…By using data from 1265 caregivers of infants and toddlers aged 0-35 months in Brazil, Altafim et al [1] conducted a study to assess the acceptability, test-retest reliability, internal consistency, and discriminate and concurrent validity of the CREDI short form. The results of qualitative interviews showed that overall acceptance of the scale was high.…”

Section: Existing Measures Of Ecdmentioning

confidence: 99%

“…We imposed strict quality control during data collection to avoid missing data and there were no missing data at the item level of the CREDI and Bayley-III, and less than 2% missing values at the item level of the ASQ-3. Second, there is less than 0.05% of child and family characteristics data missing in our sample, thus, we excluded this 1 Trial registration: ISRCTN, ISRCTN16736104.Registered 25 May 2018, https://doi.org/10.1186/ISRCTN16736104 2 According to the CREDI's user guide, cultural adaptation of the CREDI is not required. Nevertheless, appropriate translation of the CREDI is critical to its utility and comparability as a population-level measure.…”

Section: Data Collectionmentioning

confidence: 99%

“…Newly developed scales used to measure ECD status at the population level, the CREDI, 3 aim to provide an accurate and easy-to-administer assessment of ECD for children between 0 and 35 months that functions across a wide variety of cultural, linguistic, and socioeconomic contexts [1,25]. CREDI is directly tested by the child's primary caregiver using a scale that is answered "yes" or "no" (If caregivers are unsure of their response, they may also choose to respond by saying "don't know").…”

Section: Caregiver Reported Early Childhood Development Instruments (mentioning

confidence: 99%

“…The goal of the CREDI is to provide low-cost, large-scale data to facilitate policy interventions and resource allocation, while tracking global progress in alleviating ECD-related disparities around the world [27]. The reliability and validity of the CREDI have been studied and its applicability to the evaluation of ECD levels in low-and middle-income countries has been confirmed [1,25,27], but there is still a lack of research about its application in China, and there are still no studies on the application of CREDI in a longer format (henceforth, "long form"). Based on this, this paper introduces and analyzes the application of the CREDI long form in China, with special focus on its reliability and validity, based on survey data from poverty-stricken areas in China.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Reliability and validity of the Caregiver Reported Early Development Instruments (CREDI) in impoverished regions of China

et al. 2020

View full text Add to dashboard Cite

Background There is a great need in low- and middle- income countries for sound qualitative and monitoring tools assessing early childhood development outcomes. Although there are many instruments to measure the developmental status of infants and toddlers, their use in large scale studies is still limited because of high costs in both time and money. The Caregiver Reported Early Development Instruments (CREDI), however, were designed to serve as a population-level measure of early childhood development for children from birth to age three, and have been used in 17 low- and middle-income countries. This study aimed to examine the reliability and validity of the CREDI in China, which is still unknown. Methods The CREDI and the ASQ-3 was administered to a sample of 946 children aged 5–36 months from urban and rural communities, in which 248 children was administered with Bayley-III. Results The internal consistency of the CREDI was high, which indicates that the scale internal consistency reliability is quite good. The results also indicated that the concurrent validity of the CREDI with the Bayley-III scale was high in general. Ordinary least squares regression showed that the CREDI is highly consistent with previous widely used instruments in some key predictors (such as the home stimulation) of early childhood development level. Conclusions All the results in the current study indicate that the CREDI may be considered an appropriate instrument to measure early childhood development status on a large scale in impoverished regions of China.

show abstract

Section: Existing Measures Of Ecdmentioning

confidence: 99%

Section: Data Collectionmentioning

confidence: 99%

Section: Caregiver Reported Early Childhood Development Instruments (mentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Reliability and validity of the Caregiver Reported Early Development Instruments (CREDI) in impoverished regions of China

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Atualmente, existem, na literatura, diversos estudos sobre a importância dos cuidados na infância (ALTAFIM et al, 2020). Todavia, ainda são poucos os trabalhos sobre o papel de um visitador atuando em conjunto com as famílias para o desenvolvimento de seus filhos, apesar do impacto ser reconhecido (SANTOS et al, 2019).…”

Section: Introductionunclassified

Ludicidade Para Evoluir: Atuação E Percepções De Uma Visitadora Do Programa Primeira Infância Melhor

SILVA¹,

COLOMé²

2021

Anais Da VII Jornada Internacional De Enfermagem, Edição 2021

View full text Add to dashboard Cite

Este estudo tem como objetivo relatar a experiência de uma visitadora do programa Primeira Infância Melhor, acerca da atuação e atividades realizadas com as famílias inscritas no programa. Foram realizadas atividades com 17 famílias, constituídas por gestantes ou crianças de zero a seis anos. Cada família recebeu um atendimento singular a fim de desenvolver, principalmente, áreas como: motricidade, cognição, socioafetividade, linguagem e comunicação. O programa também visa facilitar o acesso ao serviço de saúde, dado que os visitadores estão inseridos semanalmente na rotina familiar, identificando demandas e realizando o encaminhamento ao setor responsável. O estudo mostrou a importância do programa no auxílio ao desenvolvimento na primeira infância, fortalecendo relações e favorecendo o bem-estar e segurança. Devido a isso, o Primeira Infância Melhor é um processo transformador para as famílias e para quem atua, visto que a vivência transforma o visitador em um profissional acolhedor e humano.

show abstract

The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations

Wyszynski¹,

Bhattacharya²,

Martínez-Pérez

et al. 2023

Drug Saf

View full text Add to dashboard Cite

Introduction The advent of the coronavirus disease 2019 (COVID-19) pandemic has led to the development of vaccines against severe acute respiratory syndrome coronavirus 2. Prospective evidence regarding safety for pregnant people and their developing fetuses is lacking. The aim of the COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER) is to estimate the relative risk of obstetric, neonatal, and infant outcomes by comparing participants vaccinated against COVID-19 during pregnancy to a reference group of people enrolled in the Pregistry International Pregnancy Exposure Registry (PIPER) who remained unvaccinated during pregnancy. Methods The C-VIPER and the PIPER are international, non-interventional, real-world cohort studies. Participants receiving a COVID-19 vaccine during pregnancy will be matched in the analyses by country and gestational age at enrollment to unvaccinated individuals. Self-enrolled and self-consented participants complete online questionnaires at enrollment, during pregnancy, and for 12 months after the delivery of a live infant. Where possible, outcomes are verified by medical records. The study aims to recruit at least 500 pregnancies for each approved or authorized vaccine and will last for 5 years for each product. Conclusions By collecting data for each vaccine brand, the C-VIPER will be able to determine individual safety profiles. The study design allows for analysis of the effects of exposure to COVID-19 vaccines during specific etiologically relevant periods of gestation. Although the sample size may be too small to detect associations with rare outcomes, the study will be used to generate hypotheses for future research. Ultimately, the C-VIPER should provide data that will allow pregnant people and their healthcare providers to make informed decisions about COVID-19 vaccination. Clinical Trial Registration ClinicalTrials.gov NCT04705116. Registered on 12 January, 2021. EU PAS EUPAS39096. Registered on 20 January, 2021.

show abstract

Measuring early childhood development in Brazil: validation of the Caregiver Reported Early Development Instruments (CREDI)

Abstract: The results suggested that the CREDI short form is a valid, reliable, and acceptable measure of early childhood development for children under the age of 3 years in Brazil.

Cited by 27 publications

References 15 publications

Reliability and validity of the Caregiver Reported Early Development Instruments (CREDI) in impoverished regions of China

Reliability and validity of the Caregiver Reported Early Development Instruments (CREDI) in impoverished regions of China

Ludicidade Para Evoluir: Atuação E Percepções De Uma Visitadora Do Programa Primeira Infância Melhor

The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations

Contact Info

Product

Resources

About